Skip to main content
Log in

In vitro and in vivo activity of lignan lactones derivatives against Trypanosoma cruzi

  • Original Paper
  • Published:
Parasitology Research Aims and scope Submit manuscript

Abstract

The trypanocidal effect of six lignan lactones, (−)-cubebin (1), (−)-O-methyl cubebin (2), (−)-O-benzyl cubebin (3), (−)-6,6′-dinitrohinokinin (4), (−)-hinokinin (5) and dimethoxymorelensin (6), previously synthesized by our research group, was evaluated in vitro and in vivo. The compounds with higher anti-epimastigote activity were screened against intracellular amastigote of Trypanosoma cruzi. Among these, compound 5 was selected to be assayed in vivo. It was observed that compounds 5, 6 and 2 showed higher trypanocidal activity against epimastigote forms of T. cruzi, displaying inhibitory concentration (IC50) values of 0.67, 3.89 and 31.35 μM, respectively. These compounds were also evaluated against intracellular amastigote forms of T. cruzi, with five displaying similar activity to benznidazole. In vivo assays showed significant reduction of parasitaemia after administration of five in mice infected.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Bastos JK, Gottlieb OR, Sarti SJ, Santos Filho D (1996) The isolation of lignans and sesquiterpenoids from leaves of Zanthoxylum naranjillo. Nat Prod Lett 9:65–70

    CAS  Google Scholar 

  • Bastos JK, Albuquerque S, Silva ML (1999) Evaluation of the trypanocidal activity of lignans isolated from the leaves of Zanthoxylum naranjillo. Planta Med 65(6):541–544

    Article  PubMed  CAS  Google Scholar 

  • Bode JW, Doyle MP, Protopopova MN, Zhou QL (1996) Intramolecular regioselective insertion into unactivated prochiral carbon–hydrogen bonds with diazoacetates catalyzed by chiral dirhodium(II) carboxamidates. Highly enantioselective total synthesis of natural lignan lactones. J Org Chem 61:9146–9155

    Article  CAS  Google Scholar 

  • Buckner FS, Verlinde CL, La Flamme AC, Van Voorhis WC (1996) Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing betagalactosidase. Antimicrob Agents Chemother 40:2592–2597

    PubMed  CAS  Google Scholar 

  • Brener Z (1962) Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev Inst Med Trop São Paulo 4:389–396

    PubMed  CAS  Google Scholar 

  • Castellani O, Ribeiro LV, Fernandes JF (1967) Differentiation of Trypanosoma cruzi in culture. J Protozool 14(3):447–451

    PubMed  CAS  Google Scholar 

  • Croft SL (1997) The current status of antiparasite chemotherapy. Parasitology 114(Suppl):3–15

    Google Scholar 

  • da Silva R, de Souza GH, da Silva AA, de Souza VA, Pereira AC, Royo Vde A, E Silva ML, Donate PM, de Matos Araujo AL, Carvalho JC, Bastos JK (2005) Synthesis and biological activity evaluation of lignan lactones derived from (−)-cubebin. Bioorg Med Chem Lett 15(4):1033–1037

    Article  PubMed  Google Scholar 

  • de Castro SL (1993) The challenge of Chagas’ disease chemotherapy: an update of drugs assayed against Trypanosoma cruzi. Acta Trop 53(2):83–98

    Article  PubMed  Google Scholar 

  • de Souza VA, da Silva R, Pereira AC, Royo Vde A, Saraiva J, Montanheiro M, de Souza GH, da Silva Filho AA, Grando MD, Donate PM, Bastos JK, Albuquerque S, e Silva ML (2005) Trypanocidal activity of (−)-cubebin derivatives against free amastigote forms of Trypanosoma cruzi. Bioorg Med Chem Lett 2005 15(2):303–307

    Article  Google Scholar 

  • Docampo R (2001) Recent developments in the chemotherapy of Chagas disease. Curr Pharm Des 7(12):1157–1164

    Article  PubMed  CAS  Google Scholar 

  • Filardi LS, Brener Z (1987) Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Trans R Soc Trop Med Hyg 81(5):755–759

    Article  PubMed  CAS  Google Scholar 

  • Heleno VCG, da Silva R, Pedersoli S, Albuquerque S, Bastos JK, e Silva MLA, Donate PM, da Silva GVJ, Lopes JLC (2006) Detailed 1H and 13C NMR structural assignment of three biologically active lignan lactones. Spectrochim Acta Part A 63:234–239

    Article  Google Scholar 

  • Martinez-Diaz RA, Escario JA, Nogal-Ruiz JJ, Gomez-Barrio A (2001) Biological characterization of Trypanosoma cruzi strains. Mem Inst Oswaldo Cruz 96(1):53–59

    Article  PubMed  CAS  Google Scholar 

  • Muelas-Serrano S, Le-Senne A, Fernandez-Portillo C, Nogal JJ, Ochoa C, Gomez-Barrio A (2002) In vitro and in vivo anti-Trypanosoma cruzi activity of a novel nitro-derivative. Mem Inst Oswaldo Cruz 97(4):553–557

    Article  PubMed  CAS  Google Scholar 

  • Murta SM, Gazzinelli RT, Brener Z, Romanha AJ (1998) Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox. Mol Biochem Parasitol 93(2):203–214

    Article  PubMed  CAS  Google Scholar 

  • Ochoa C, Perez E, Perez R, Suarez M, Ochoa E, Rodriguez H, Gomez Barrio A, Muelas S, Nogal JJ, Martinez RA (1999) Synthesis and antiprotozoan properties of new 3,5-disubstituted-tetrahydro-2H-1,3,5-thiadiazine-2-thione derivatives. Arzneim-Forsch 49(9):764–769

    CAS  Google Scholar 

  • Paulino M, Iribarne F, Dubin M, Aguilera-Morales S, Tapia O, Stoppani AO (2005) The chemotherapy of Chagas’ disease: an overview. Mini Rev Med Chem 5(5):499–519

    Article  PubMed  CAS  Google Scholar 

  • Rodriques Coura J, de Castro SL (2002) A critical review on Chagas’ disease chemotherapy. Mem Inst Oswaldo Cruz 97(1):3–24

    Article  PubMed  Google Scholar 

  • Rolon M, Seco EM, Vega C, Nogal JJ, Escario JA, Gomez-Barrio A, Malpartida F (2006) Selective activity of polyene macrolides produced by genetically modified Streptomyces on Trypanosoma cruzi. Int J Antimicrob Agents 28(2):104–109

    Article  PubMed  CAS  Google Scholar 

  • Souza GH, da Silva Filho AA, de Souza VA, Pereira AC, Royo Vde A, e Silva ML, da Silva R, Donate PM, Carvalho JC, Bastos JK (2004) Analgesic and anti-inflammatory activities evaluation of (−)-O-acetyl, (−)-O-methyl, (−)-O-dimethylethylamine cubebin and their preparation from (−)-cubebin. Farmaco 59(1):55–61

    Article  PubMed  CAS  Google Scholar 

  • Urbina JA, Docampo R (2003) Specific chemotherapy of Chagas’ disease: controversies and advances. Trends Parasitol 19(11):495–501

    Article  PubMed  CAS  Google Scholar 

  • Vega C, Rolon M, Martinez-Fernandez AR, Escario JA, Gomez-Barrio A (2005) A new pharmacological screening assay with Trypanosoma cruzi epimastigotes expressing β-galactosidase. Parasitol Res 95(4):296–298

    Article  PubMed  CAS  Google Scholar 

  • WHO (2003) http://www.who.int/tdr/dw/chagas2003.htm

Download references

Acknowledgment

We would like to thank FAPESP for the financial support. The undertaken experiments comply with the current laws of the country in which they were performed.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Juliana Saraiva.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saraiva, J., Vega, C., Rolon, M. et al. In vitro and in vivo activity of lignan lactones derivatives against Trypanosoma cruzi . Parasitol Res 100, 791–795 (2007). https://doi.org/10.1007/s00436-006-0327-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00436-006-0327-4

Keywords

Navigation